Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279236 · ClinicalTrials.gov registry record
Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)
A clinical trial, sponsored by Oticon Medical.
- Completed
- Registry status
- 64
- Enrollment target
NCT04279236 is a clinical trial that has completed, run by Oticon Medical. The registered enrollment target is 64 participants.
The verdict
NCT04279236 has completed, sponsored by Oticon Medical.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
This prospective, multi-center study funded by Oticon Medical AB will be conducted at six clinical sites in North America. Patients with a hearing loss and that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study. The total number of participants included in the study will be 64. The purpose of this study is to investigate the rate of successful BAHS use after implantation of the Ponto Implant system using the surgical technique Minimally Invasive Ponto Surgery (MIPS).
Interventions
- OTHER Abbreviated Profile Hearing Aid Benefit (APHAB)
- OTHER Glasgow Benefit Inventory (GBI)
- OTHER Additional follow-up visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2024-12-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279236
The ClinicalTrials.gov registry entry for NCT04279236 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oticon Medical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Abbreviated Profile Hearing Aid Benefit (APHAB) is the first listed.
NCT04279236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279236 about?
NCT04279236 is a clinical study titled "Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)". This prospective, multi-center study funded by Oticon Medical AB will be conducted at six clinical sites in North America. Patients with a hearing loss and that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study....
What is the current status of trial NCT04279236?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2020-06-15. Estimated completion is 2024-12-10.
What interventions are being tested in trial NCT04279236?
The interventions under investigation include: Abbreviated Profile Hearing Aid Benefit (APHAB) (OTHER), Glasgow Benefit Inventory (GBI) (OTHER), Additional follow-up visit (OTHER).
Who is sponsoring clinical trial NCT04279236?
This trial is sponsored by Oticon Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.